ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Fisher, NSABP Executive Committee, File Injunction Seeking Herberman’s Removal

August 12, 1994

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

Regular NSAIDs Use Protects Smokers From Lung Cancer

March 28, 2003

French Legion d’Honneur Bestowed On Hortobagyi.

March 1, 2002

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013

Three Nominated To ET2; NCI Seeks Clinical Applications

May 24, 1991